三顺SANSHUN品牌怎么样 申请店铺

我要投票 三顺SANSHUN在滴眼液行业中的票数:507 更新时间:2025-07-06
三顺SANSHUN是哪个国家的品牌?「三顺SANSHUN」是 长春普华制药股份有限公司 旗下著名品牌。该品牌发源于吉林省长春市,在1997年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力三顺SANSHUN品牌出海!将品牌入驻外推网,定制三顺SANSHUN品牌推广信息,可以显著提高三顺SANSHUN产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

三顺SANSHUN怎么样

始建于1997年,以生产中成药、生化学药品为主的综合性企业,其复方熊胆滴眼液对于治疗细菌性眼结膜炎、流行性角结膜炎有显著功效


长春普华制药股份有限公司始建于1997年11月,主要从事中成药、化学药品的研发、生产和销售,是吉林省高新技术企业、GMP认证企业。公司坐落于美丽的北方春城长春市,位于高新产业技术开发区火炬路1105号,占地面积27000平方米,GMP车间及建筑面积约12000平方米。

长春普华制药股份有限公司是融研发、生产、销售于一体,以生产中成药、生化学药品为主的综合性制药企业。公司拥有生产设备,科学的管理体系,雄厚的研发力量,产品质量及精锐的销售队伍。公司产品涉及五官科、皮肤科、肌肉-骨骼系统疾病、心脑血管疾病、呼吸系统疾病等多个医疗领域,涵盖了滴眼剂、膏剂、小容量注射剂、滴丸剂、片剂、胶囊剂、颗粒剂、原料药等剂型。公司已形成“以中成药为特色,以眼科用药和皮肤科用药为主,肌肉骨骼系统及其他领域用药为辅”的产品格局,主要产品包括复方熊胆滴眼液、苄达赖氨酸滴眼液、近视乐眼药水、丹皮酚软膏、辣椒碱乳膏、益心酮滴丸等,产品特色鲜明,在特定治疗领域和细分市场具有独特的竞争优势。在产品储备方面,公司拥有多个具备产业化条件且市场潜力大的优质产品。

公司新药研发实力雄厚,拥有一支以研发人员为主的新药研发队伍。多年来在基因工程药物、现代中药等领域投入了大量研发资金,一批具有自主知识产权的高水平新药已经进入新药申报程序,为公司的发展奠定了坚定的基础。

公司以“服务社会、承担责任、关注员工、共同成长”为企业经营理念,以“责任、忠诚、执行、敬业、荣誉”为企业精神,经营水平不断提高,营销网络遍布全国各地,优质的产品受到患者的一致好评。


Founded in 1997, it is a comprehensive enterprise mainly engaged in the production of Chinese patent medicine and biochemical medicine. Its compound bear bile eye drops have significant effect on the treatment of bacterial conjunctivitis and epidemic keratoconjunctivitis. Changchun Puhua Pharmaceutical Co., Ltd. was founded in November 1997, mainly engaged in the research, development, production and sales of Chinese patent medicine and chemical medicine. It is a high-tech enterprise and GMP certified enterprise in Jilin Province Industry. The company is located in the beautiful North Spring City Changchun City, No. 1105, Torch Road, hi tech Development Zone, covering an area of 27000 square meters, GMP workshop and building area of about 12000 square meters. Changchun Puhua Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise integrating R & D, production and sales, focusing on the production of proprietary Chinese medicine and biochemical drugs. The company has production equipment, scientific management system, strong R & D force, product quality and excellent sales team. Our products cover many medical fields, such as facial features, dermatology, musculoskeletal system diseases, cardiovascular and cerebrovascular diseases, respiratory system diseases, etc., including eye drops, poultices, small volume injections, pills, tablets, capsules, granules, APIs and other dosage forms. The company has formed a product pattern of "with Chinese patent medicine as the feature, ophthalmology and dermatology as the main drug, musculoskeletal system and other fields as the auxiliary drug". The main products include compound bear bile eye drops, benzyl lysine eye drops, myopic eye drops, paeonol ointment, capsaicin cream, yixinke pills and so on. The products have distinctive characteristics and are subdivided in specific treatment fields The market has a unique competitive advantage. In terms of product reserve, the company has a number of high-quality products with industrialization conditions and great market potential. The company has strong R & D strength of new drugs, with a new drug R & D team mainly composed of R & D personnel. Over the years, a large number of R & D funds have been invested in the fields of genetic engineering drugs, modern Chinese medicine and so on. A batch of high-level new drugs with independent intellectual property rights have entered the new drug application process, laying a solid foundation for the development of the company. The company takes "serving the society, taking responsibility, paying attention to employees and growing up together" as its business philosophy, and "responsibility, loyalty, implementation, dedication and honor" as its corporate spirit. Its business level is constantly improving. Its marketing network is spread all over the country, and its high-quality products are highly praised by patients.

本文链接: https://brand.waitui.com/056f4e0ca.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

斯迪克:公司OCA产品在三星供应链的合作暂未批量供货

36氪获悉,斯迪克在互动平台表示,目前公司的OCA产品在三星供应链的相关合作尚处于样品测试评估阶段,暂未形成批量供货。

2小时前

盘古团队最新声明:严格遵循开源要求

36氪获悉,7月5日下午,华为诺亚方舟实验室在官方平台发布最新声明称,盘古Pro MoE开源模型是基于昇腾硬件平台开发、训练的基础大模型,并非基于其他厂商模型增量训练而来。上述团队表示,“盘古Pro MoE开源模型部分基础组件的代码实现参考了业界开源实践,涉及其他开源大模型的部分开源代码。我们严格遵循开源许可证的要求,在开源代码文件中清晰标注开源代码的版权声明。这不仅是开源社区的通行做法,也符合业界倡导的开源协作精神。”

2小时前

顺德农商行撤回IPO申请

7月4日,深交所发行上市审核信息公开网站显示,因广东顺德农村商业银行股份有限公司、保荐人撤回发行上市申请,深交所决定终止其发行上市审核。截至目前,处于A股上市“候场区”的银行仅剩5家,分别是湖州银行、江苏昆山农商银行、湖北银行、广东南海农商银行、东莞银行,其中仅湖州银行处于“已问询”状态。(界面)

2小时前

美团即时零售日订单突破1亿,较去年峰值提前33天

7月5日晚,美团向内部员工推送的战报显示,截至20时45分,美团即时零售日订单量突破1亿单。今年美团订单峰值比去年提前了33天,去年8月7日美团日订单超过了9000万。据媒体报道,今年6月以来美团的日订单连续保持在9000万以上。这一峰值是在外卖迎来激烈竞争的局面下取得的。在这次的内部战报中,美团多次提及了“用户体验”,强调“继续为用户创造最佳体验”。

2小时前

美团即时零售日订单已突破1.2亿,餐饮订单占比过亿

据美团内网公布信息显示,截至22时54分,美团即时零售当日订单已经突破了1.2亿单,其中,餐饮订单已超过1亿单。值得注意的是,就在当晚20时45分,美团内网曾显示即时零售日订单突破了1亿。这也意味着,在2个小时的时间内,美团已产生了超过2000万笔订单。考虑到周末夜宵时段仍然是外卖高峰期,这一数据目前仍在增长中。7月5日是暑期消费旺季正式开启后的第一个周末,也是外卖消费的传统促销季。公开报道显示,去年夏天美团的订单峰值超过了9000万单。

2小时前

本页详细列出关于三顺SANSHUN的品牌信息,含品牌所属公司介绍,三顺SANSHUN所处行业的品牌地位及优势。
咨询